Showing results (781-790 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|February 21, 2018
Cost-effectiveness of hydrophilic-coated intermittent catheters compared with uncoated catheters in Canada: a public payer perspectiveBlayne Welk, Wanrudee Isaranuwatchai, Andrei Krassioukov, et al.Journal of Medical Economics|August 24, 2017
Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis CMark P Connolly, Nikos Kotsopoulos, Andrew UstianowskiJournal of Medical Economics|July 29, 2021
Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of lifeCathleen Collins, Julie J Kim-Chang, Elena Hsieh, et al.Journal of Medical Economics|July 27, 2021
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASDDarshan Mehta, Matthew Davis, Andrew J Epstein, et al.Journal of Medical Economics|March 28, 2017
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care unitsJesus Ruiz-Ramos, Juan Frasquet, Eva Romá, et al.Journal of Medical Economics|November 1, 2018
Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparisonSaeed Taheri, Mohammad Ali Sahraian, Nazila YousefiJournal of Medical Economics|April 21, 2017
Economic evaluation of ezetimibe treatment in combination with statin therapy in the United StatesGlenn M Davies, Ami Vyas, Carl A BaxterJournal of Medical Economics|October 27, 2016
A case-control comparison of direct healthcare-provider medical costs of chronic idiopathic constipation and irritable bowel syndrome with constipation in a community-based cohortLinda M Herrick, William M Spalding, Yuri A Saito, et al.Journal of Medical Economics|October 6, 2016
A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in DenmarkR F Pollock, C K TikkanenJournal of Medical Economics|October 27, 2016
Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolismCraig I Coleman, Christopher Baugh, Concetta Crivera, et al.Pageof 241